Found 10 matching trials
A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK233705 In Healthy Volunteers. PHASE1 This study will investigate the safety and tolerability of inhaled doses of...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects. PHASE1 GW642444 and GSK233705 are in development for treatment of Chronic Obstruct...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Dose-Ranging Study Of GSK233705B In Subjects With Chronic Obstructive Pulmonary Disease (COPD) PHASE2 The purpose of this study is to evaluate the efficacy and safety of GSK2337...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety Study Using GSK233705 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease PHASE1 GSK233705 is a high-affinity specific muscarinic receptor (mAChR) antagonis...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Phase I Study of GSK233705 in Healthy Japanese Male Subjects PHASE1 This is a randomised, double blind, placebo-controlled, 2-parts study to in...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study To Examine Safety, Tolerability And Pharmacokinetics Of Intravenous Doses And Oral Dose Of GSK233705 PHASE1 GSK233705 is being developed for the treatment of chronic obstructive pulmo...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD) PHASE2 The safety, tolerability, pharmacokinetics and pharmacodynamics/efficacy pr...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety And Tolerability Study In Patients With Chronic Obstructive Pulmonary Disease PHASE2 GSK233705 is a high-affinity specific muscarinic receptor (mAChR) antagonis...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety and Tolerability of Repeat Dosing of GSK233705/GW642444 in COPD PHASE2 The purpose of this study is the evaluate the safety and tolerability of re...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects PHASE1 GW642444 and GSK233705 are in development for treatment of Chronic Obstruct...
Show More Location
GSK Investigational Site
Learn More & Join Trial